Form 4 Filing: Shegog Todd Acquires (Grant) shares of $MTRI

STOCK AWARD / GRANT

⚡ MATERIALITY: 1/10

corporate issuer

InMed Pharmaceuticals Inc.

Ticker: $MTRI

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-11-09

Shares: 37,000

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Shegog Todd, holds the title of Director at InMed Pharmaceuticals Inc..

On 2026-11-09, the insider transacted 37,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

Shegog Todd (Director) was granted $0 of $MTRI

Post-Transaction Position: 37,000 shares

SEC Accession No: 0001193125-26-458548 (CIK: 1714564)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$MTRI Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$MTRI News Coverage